deltatrials
Completed NA INTERVENTIONAL 3-arm NCT05383300

Intranasal Oxytocin in Antiosocial Personality Disorder and Psychopathy (OXYASP)

Investigating the Effect of Oxytocin and the Neurochemistry of Antisocial Personality Disorder and Psychopathy Using Neuroimaging

Sponsor: Father Flanagan's Boys' Home

Conditions Antisocial Personality Disorder
Interventions Oxytocin nasal spray Placebo spray
Updated 3 times since 2022 Last updated: May 16, 2022 Started: May 1, 2017 Primary completion: Mar 1, 2020 Completion: Dec 1, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Antisocial Personality Disorder, this trial is completed. The trial is conducted by Father Flanagan's Boys' Home and has accumulated 3 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jun 2022 – ~Jul 2024 · 25 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

3 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jun 2022 — Jul 2024 [monthly]

    Completed NA

    First recorded

May 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Father Flanagan's Boys' Home
  • King's College London
Data source: King's College London

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations